PRECISIS GmbH
Precisis is a company specializing in bioelectronic methods and neurostimulation therapies, with a focus on developing innovative brain stimulation devices like EASEE® for treating drug-resistant focal epilepsies. Their mission is to improve brain function and quality of life through technological innovation in neuromodulation, expanding applications to depression therapy and stroke medicine.
Industries
Nr. of Employees
small (1-50)
PRECISIS GmbH
Products
Implantable minimally invasive cortical neuromodulation system for drug‑resistant focal epilepsy
An implanted neuromodulation system that uses subcutaneous cortical electrodes and a miniaturized implantable stimulator to suppress epileptic seizures in patients with focal epilepsy refractory to medication.
Implantable minimally invasive cortical neuromodulation system for drug‑resistant focal epilepsy
An implanted neuromodulation system that uses subcutaneous cortical electrodes and a miniaturized implantable stimulator to suppress epileptic seizures in patients with focal epilepsy refractory to medication.
Services
Neurostimulation device design and development
Design-house R&D services covering concept development, device miniaturization, electrode engineering, and prototyping for implantable neurostimulation systems.
Neurostimulation device design and development
Design-house R&D services covering concept development, device miniaturization, electrode engineering, and prototyping for implantable neurostimulation systems.
Expertise Areas
- Clinical neuromodulation for focal epilepsy
- Implantable neurodevice design and miniaturization
- AI-driven neural modulation
- Cortical electrode development
Key Technologies
- Subcutaneous cortical electrodes
- Implantable bioelectronic stimulators (miniaturized IPGs)
- Machine-learning-driven stimulation algorithms
- Targeted cortical current delivery